News Industry News Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension July 28, 2015
News Industry News Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet July 23, 2015
News Industry News Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection July 09, 2015
News Daily News Higher BMI Linked to Lower Mortality, More Metabolic Disorders After PCI L.A. McKeown April 12, 2011